Joshua Cohen is a Boston-based writer who covers health policy. Bluebird bio is a highly innovative biotechnology company which develops gene therapies for several rare genetic disorders and cancers.

Under the terms of the amended agreement bluebird stockholders can elect to receive either (x) the original offer of $3.00 per share in cash plus a contingent value right (“CVR”) of $6.84 per ...

Bluebird Bio, Inc. (NASDAQ:BLUE) shares are trading higher on Wednesday following the news that Bluebird Bio, Carlyle, and SK Capital Partners, LP, have amended their definitive agreement.

The Jacksonville Aviation Authority will vote on nearly $35 million in airport improvements and incentives to attract a passenger jet manufacturer codenamed Project Bluebird to Cecil Airport.

The Bluebird Theater may not immediately spring to mind. It’s not that fancy, nor that big. But its history says reams about the Mile High City. The gorgeous, blue-neon sign jumps out from its ...

The singer's latest single brought in 62% of the vote. By Mitchell Peters Lana Del Rey‘s “Bluebird” tops this week’s new music poll. In a poll published Friday (April 18) on Billboard ...

Lana Del Rey dropped her new country-tinged single “Bluebird” on Friday and shared a story about how the song was inspired by a real-life bird that brought her a sign she should have listened to.

By McKinley Franklin Lana Del Rey’s new song, “Bluebird,” is out. The American singer-songwriter dropped her latest track Friday, the second single off her upcoming 10th studio album.

Though its accompanying album might again be subject to a sense of mystery, "Bluebird" proves Lana Del Rey knows exactly what she's doing in her new era. By Tyler Jenke Lana Del Rey fans have ...

Today (April 18), she’s back with more as she has shared another new single, the delicate “Bluebird.” To open the song, Del Rey sings, “Little bird, bluebird / Fly away for both of us ...

Ayrmid proposed acquiring Bluebird for $4.50 per share in cash plus a $6.84 per share contingent value right based on a net sales milestone. Bluebird previously agreed to a $3.00 per share buyout ...

Bluebird Bio has received a competing bid from Ayrmid to buy the cash-strapped gene-therapy company in a deal potentially valued at up to $110.5 million. Bluebird said late Friday that Ayrmid made ...